The discovery of novel sanjuanolide derivatives as chemotherapeutic agents targeting castration-resistant prostate cancer.

The discovery of novel sanjuanolide derivatives as chemotherapeutic agents targeting castration-resistant prostate cancer.
复制标题

发现新型三胡内酯衍生物作为针对去势抵抗性前列腺癌的化疗药物。

DOI:
10.1016/j.bioorg.2021.104880
复制
发表时间:
2021-03
影响因子:
5.1
通讯作者:
Zheng Xiaohui
Zheng Xiaohui
中科院分区:
化学1区
文献类型:
--
作者:
Wang Guangbao;Chen Xiaojing;Wang Nan;Xiao Yunbei;Shu Sheng;Alsayed Ali Mohammed Mohammed;Liu Lu;Ma Yue;Liu Peng;Zhang Qianwen;Chen Xiangjuan;Liu Zhiguo;Zheng Xiaohui

文献摘要

参考文献

相似文献

仍然迫切需要更有效的治疗去势抵抗性前列腺癌(CRPC)的疗法,CRPC是前列腺癌患者死亡的主要原因。本研究设计、合成了一系列具有潜在抗CRPC活性的圣胡安碱衍生物。大多数化合物对CRPC细胞具有良好的选择性,IC 50值< 20 µM。此外,观察到对人正常肝MIHA细胞和正常前列腺基质肌成纤维细胞WPMY-1细胞的最小副作用,IC 50> 100 µM。代表性化合物S 07可减慢CRPC细胞的增殖速率,促进细胞凋亡,并导致G2/M期细胞聚集,G1/G 0期细胞减少。进一步的机制研究表明,S 07处理引发了强烈的DNA损伤,并以剂量依赖的方式引起了强烈的DNA损伤反应。这些结果表明,圣胡安碱衍生物,特别是S 07,通过引发强烈的DNA损伤和DNA损伤反应,选择性地诱导CRPC细胞死亡。
There remains a critical need for more effective therapies for the treatment of castration-resistant prostate cancer (CRPC), which is the leading cause of death in patients with prostate cancer. In this study, a series of sanjuanolide derivatives were designed, synthesized and evaluated as potential anti-CRPC agents. Most of the compounds had excellent selectivity for CRPC cells withIC50values < 20 µM. Moreover, minimal side effects on human normal hepatic MIHA cells and normal prostatic stromal myofibroblast WPMY-1 cells were observed, withIC50> 100 µM. The representative compoundS07slowed down the proliferative rate of CRPC cells, promoted cell apoptosis and caused G2/M phase accumulation, as well as G1/G0 phase reduction. Further mechanistic studies showed that S07treatment triggered intense DNA damage and provoked strong DNA damage response in a dose-dependent manner. These findings suggested that sanjuanolide derivatives, especiallyS07,selectively induced CRPC cell death by triggering intense DNA damage and DNA damage response.
DOI: 10.1039/c2dt31303k
发表时间: 2012-09
影响因子: 4
作者:
Xiao-Hui Zheng;Y. Zhong;Cai-Ping Tan;L. Ji;Z. Mao
通讯作者: Xiao-Hui Zheng;Y. Zhong;Cai-Ping Tan;L. Ji;Z. Mao
DOI: 10.1038/nprot.2006.5
发表时间: 2006-01-01
期刊: NATURE PROTOCOLS
影响因子: 14.8
作者:
Olive, Peggy L.;Banath, Judit P.
通讯作者: Banath, Judit P.
DOI: 10.1074/jbc.274.33.22932
发表时间: 1999-08-13
影响因子: 4.8
作者:
Boulares, AH;Yakovlev, AG;Smulson, M
通讯作者: Smulson, M
DOI: 10.1021/acs.jnatprod.5b00908
发表时间: 2016-03-25
影响因子: 5.1
作者:
Shaffer CV;Cai S;Peng J;Robles AJ;Hartley RM;Powell DR;Du L;Cichewicz RH;Mooberry SL
通讯作者: Mooberry SL
DOI: 10.3747/co.v17i0.718
发表时间: 2010-09
期刊: Current oncology
影响因子: 2.6
作者:
S. Hotte;F. Saad
通讯作者: S. Hotte;F. Saad